• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

The millennial generation has split, new Fed research shows: Those over 35 are edging toward boomer-style wealth, while everyone else falls behind

2

Scott Bessent casually says the U.S. has more than $1 trillion in gold—and that it doesn’t matter for the dollar

3

Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stock

1

The millennial generation has split, new Fed research shows: Those over 35 are edging toward boomer-style wealth, while everyone else falls behind

2

Scott Bessent casually says the U.S. has more than $1 trillion in gold—and that it doesn’t matter for the dollar

3

Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stock
HealthOzempic

Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs

By
Amanda Loudin
Amanda Loudin
Down Arrow Button Icon
By
Amanda Loudin
Amanda Loudin
Down Arrow Button Icon
June 27, 2024, 8:00 PM ET
Wegovy, an injectable prescription weight-loss medicine, has helped people with obesity.
Wegovy, an injectable prescription weight-loss medicine, has helped people with obesity. Michael Siluk/UCG/Universal Images Group via Getty Images
Add Fortune on Google for similar content.

When GLP-1 drugs for diabetes and weight loss, exploded onto the scene two years ago, patients scrambled to get their hands on them. GLP-1s, which include Ozempic, Wegovy, Mounjaro, and Zepbound, are so popular that it didn’t take long for them to wind up in short supply. According to one recent survey conducted by KFF Health Tracking, as many as one in eight adults has now used a GLP-1.

Recommended Video

The demand shows no signs of slowing down, and as a result, counterfeit GLP-1 drugs are becoming an increasingly bigger piece of the landscape—so big, in fact, that the World Health Organization (WHO) last week issued a warning to people to be wary of the fake versions. Alongside the warning, drug makers Eli Lilly and Novo Nordisk have filed lawsuits against several entities to stop selling the counterfeits.

“As soon as these drugs hit the market, the demand was so high that pharmacies began running out of them,” says Dr. Supriya Rao of Integrated Gastroenterology Consultants in Boston. “So med spas and compounding pharmacies began filling that gap for patients.”

A compounding pharmacy creates medicines using base ingredients, rather than dispensing the name-brand medications like Ozempic and Wegovy. Med spas, many online sources, and compounding pharmacies do not fall under the umbrella of FDA regulation, so there are no safeguards on what a patient might receive from one of these sources. “Compounded medications are essentially ‘copies’ of available medications, but they do not have the same safety, quality, and effectiveness assurances as approved drugs since these compounded versions lack FDA approval,” explains Dr. Carolyn Jasik, chief medical officer for Omada Health.

Likewise, counterfeit drugs—like what you might find at a med spa or from an online source—are unregulated. “Counterfeit drugs, no matter what, are dangerous and can lead to serious health consequences,” says Jasik. “These medications can contain toxic doses, the wrong ingredients, or no active ingredients at all. In short, you’re paying for a drug that can either harm you or is doing nothing at all.”

Some of the risks you might face with an unregulated form of GLP-1 include nausea and diarrhea, irregular blood sugar levels, and infections at the site of injection, among others.

Often, patients are drawn to these alternative sources not just because supply of the originals is short, but also because they can be prohibitively expensive. 

“Semaglutide medications are valuable and effective, but we are currently caught in a moment where the supply chain and cost can make these drugs inaccessible to much of the broader public,” says Jasik. “It’s important to note that this is a large part of what drives the development of counterfeit drugs in the first place. As a medical provider, I’m sad that this lifesaving medication is so difficult to access and that it’s come to counterfeit drugs that take advantage of people’s desires and medical needs.”

The take-home message: Buyer beware.

How to avoid fake Ozempic, Wegovy, and other GLP-1s

Buy from state-licensed pharmacies only

As tempting as it might be to go for the cheaper alternatives on the market—or simply just to get your hands on a GLP-1 drug—the experts recommend steering clear. “Consumers should purchase medications from state-licensed pharmacies or FDA-registered outsourcing facilities to minimize the risk of counterfeit products,” says Simona Dorf, PharmD, and clinical pharmacist at First Databank. “It’s essential to verify prescriptions from licensed health care providers and avoid drugs recommended by unverified online sources or social media influencers.”

Do your own research when purchasing any medication online

The FDA’s BeSafeRx website is a good source of credible information to educate yourself before hitting “buy.” The site warns against websites that pose as online pharmacies, and recommends consumers only buy prescription medicines from a state-licensed online pharmacy, plus offers a location tool to find one. Additionally, it recommends talking with your doctor about any meds you purchase online.

Check the packaging and labels

A sure sign that you’re dealing with a fake is misspellings on the label, or poor print quality. Give each label a good going over to make sure of its authenticity. Along with those red flags, others include a missing or added word to the drug’s name. You can also do a check on the serial numbers and lot numbers by checking the FDA’s website. 

Avoid compounding pharmacies

Rao also reminds consumers that any medication you put in your body has the potential for side effects. Those risks only grow if you’re not purchasing them from trusted sources. “Compounding pharmacies can be a slippery slope,” she says. “Depending on who is sourcing the medication, who knows what you’re getting from one day to the next. Injecting a drug from an unknown source is risky.”

There are also important steps to take with regard to weight loss, whether you are using a GLP-1 medication or not, said Jasik. These include consistent self-monitoring, like weigh-ins; maintaining a balanced diet; exercises to help build lean body mass; and lifestyle programming to create a structured approach.

Whether you choose to use a weight-loss medication or not, safety should be front and center to your approach. And if the medication is part of that, even more so. “It is crucial to cross-check such information with health care providers,” said Dorf. “Awareness of the risks associated with counterfeit GLP-1 drugs and taking proactive measures can significantly protect consumers. As demand for these medications continues to grow, vigilance from both consumers and regulatory bodies is essential to ensure safety and efficacy in treating diabetes and obesity.”

More on Ozempic, Wegovy, and GLP-1 drugs:

  • They lost weight on Wegovy. Here’s what happened when they stopped taking it
  • Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock
  • How drugs like Ozempic and Wegovy work for weight loss: ‘Food tastes good, but I don’t want it’
The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S. policy officials, top founders, and thought leaders to help define what’s next for the American economy, Nov. 16-17 in Detroit. Apply here.
About the Author
By Amanda Loudin
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

Latest in Health

NordicTrack Commercial 1750 Treadmill Review (2026): Expert Reviewed
HealthDietary Supplements
NordicTrack Commercial 1750 Treadmill Review (2026): Expert Reviewed
By Emily PharesJuly 23, 2026
6 hours ago
r
HealthDrugs
RFK Jr. calls himself a ‘big fan,’ so does Joe Rogan. Now an FDA panel is reviewing half a dozen peptides
By Matthew Perrone and The Associated PressJuly 23, 2026
6 hours ago
mm
CommentaryLeadership
Michael Muthukrishna: The ‘lone genius’ myth is wrong and it’s holding back your business
By Michael MuthukrishnaJuly 23, 2026
11 hours ago
glp
Commentaryobesity
The GLP-1 paradox: too expensive to cover, too effective to cut
By Bryan Sivak and Elina OnitskanskyJuly 23, 2026
11 hours ago
Hasbro’s growth strategy isn’t just about kids anymore—it’s about ‘kidults’
Healthchief executive officer (CEO)
Hasbro’s growth strategy isn’t just about kids anymore—it’s about ‘kidults’
By Phil WahbaJuly 23, 2026
15 hours ago
The Top Fitness and Wellness Gifts (2026): For the Busy Gym-Goer in Your Life
HealthFitness
The Top Fitness and Wellness Gifts (2026): For the Busy Gym-Goer in Your Life
By Christina SnyderJuly 22, 2026
1 day ago

Most Popular

The millennial generation has split, new Fed research shows: Those over 35 are edging toward boomer-style wealth, while everyone else falls behind
Real Estate
The millennial generation has split, new Fed research shows: Those over 35 are edging toward boomer-style wealth, while everyone else falls behind
By Nick LichtenbergJuly 22, 2026
1 day ago
Scott Bessent casually says the U.S. has more than $1 trillion in gold—and that it doesn’t matter for the dollar
Economy
Scott Bessent casually says the U.S. has more than $1 trillion in gold—and that it doesn’t matter for the dollar
By Sasha RogelbergJuly 22, 2026
1 day ago
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stock
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stock
By Sasha RogelbergJuly 20, 2026
3 days ago
'The man who dies rich dies disgraced': The last time America had such wealth inequality, Andrew Carnegie knew he had to give it all away
Success
'The man who dies rich dies disgraced': The last time America had such wealth inequality, Andrew Carnegie knew he had to give it all away
By Nick LichtenbergJuly 22, 2026
1 day ago
Spain lifted the World Cup, but the IRS still gets a cut of its $50 million pay day as players, coaches and refs all face complex U.S. “jock taxes”
Personal Finance
Spain lifted the World Cup, but the IRS still gets a cut of its $50 million pay day as players, coaches and refs all face complex U.S. “jock taxes”
By Joshua HongJuly 23, 2026
15 hours ago
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problem
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problem
By Eva RoytburgJuly 21, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.